The tech billionaire Sean Parker (co-founder of music-file sharing Napster and first president of Facebook) will fund $250 million to …

You have read of your 8 free articles this month.

Subscribe to
Medgenera All-Access

Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.

Access articles & resources worth up to US $4, 000 per month.

Authentic, Ad-free Reporting
High-quality, Exclusive Content
Original Market Research Reports
Original Resources & Databases
Global Surveys & Guidelines
Lowest Subscription Pricing

Healthcare News You Won't Read Elsewhere

Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.

Access articles & resources worth up to $4000.

More in Investments


Investments

Indian Startup Pharmarack Plans at Raising $2 Million from Multiple Investors

The Pune based firm Pharmarack Technologies Pvt Ltd is optimistic about landing a $2 million in venture capital to support ...

Investments

Investors High Interest in Novimmune’s NI-0501 for Special Orphan Disease

Swiss biotech, Novimmune’s lead compound- NI-0501 being developed for treatment of severe hyperinflammatory disease, hemophagocytic lymphohistiocytosis (HLH) has gained a ...

Investments

Now CRISPR/Cas9 IPO Revolution! Intellia Ready with $140M Plans

Intellia is setting plans to offer 6 million shares at a range of $16 to $18 in an IPO and ...

Investments

India Based Injectables Company Attracts Multiple Global Deals

Hyderabad based Gland Pharmaceuticals Ltd is attracting investors and buyers from all over the world. Global buyout firm Advent International ...

Most Popular


GROW

7 New Ideas to Start a Healthcare Business in India (2018)

Highlights Herein, we are proposing the seven new healthcare business ideas in India in 2018 which are based on our ...

NEWLY PUBLISHED

Pharma Patents: Can India Reward Incremental Innovation?

Chandramouli Natarajan is an Associate Scientist, Ricon pharma LLC, Denville, USA. He has presented his opinion and views on the Pharmaceutical patents issues in India. This article is available for free to read and share.

Leave a reply